Lenacapavir sodium | Interleukin Related interleukin-related.com

Product Name :
Lenacapavir sodium

Search keywords :
Lenacapavir

drugId :
null

Target Vo:
Capsid protein

Target Vo Short Name :
Capsid

Moa_Name:
Capsid protein inhibitors

First Approval Country :
EU

First Approval Date Filter:
2022

Origin Company_Name :
Gilead Inc

Active Company_Name :
Gilead Sciences Inc

Active Indication_Name:
HIV Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Histone H2B Rabbit mAb web
Hsp40 Mouse mAb Formula
Ku70 Antibody (YA715): Ku70 Antibody (YA715) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts